In conclusion, the frequency of the different polymorphic GR gene variants does not differ between patients and controls, and this militates against a possible pathogenetic role of the GR SNPs in development of adrenal adenomas. This evidence concerns the gene NR3C1 and adrenal cortex adenoma.